|
 |
|
Anti CRA (Crotonaldehyde) Monoclonal Antibody |
|
|
Crotonaldehyde (CRA) is produced by oxidization of lipids in a living body. CRA reacts with lysine residues in proteins to form a stable reactant (CRA-lysine). This antibody has high specificity to CRA-lysine. |
|
|
| Immunogen |
:
|
Antibody obtained by cultivating the hybridoma, which is formed by fusing the spleen cell of a BALB/c mouse sensitized with CRA modification protein and the myeloma cell of a mouse, in the abdominal cavity of the BALB/c mouse. |
| Form/Shape |
:
|
10mM Phosphoric Acid Buffer Physiologic Saline Solution containing 0.1% NaN3 and 0.5% BSA |
| Specificity |
: |
Combines specifically with CRA modification protein. |
| Class |
: |
IgG2a |
| Volume |
: |
30μg/vial (100μg/mL) |
| Storing Method |
: |
Stored at -20 degrees centigrade |
| Package |
|
2ml Vial |
|
|
|
Immunostaining of Aorta Wall Macrophage (Dilution Magnification 1:200) |
|
|
| Product Number |
Product Name |
Package |
Price (without tax) |
| N213630 |
Anti CRA Antibody |
30μg |
¥60,000- |
|
|
|
Page Top
